LONDON-- Irish drug group Merrion Pharmaceuticals PLC (3MP.DB) Thursday said it has sold some intellectual property assets to Denmark's Novo Nordisk A/S (NVO) for $3 million.

Merrion also announced amendments to license agreements with Novo Nordisk that will result in the accelerated payment by Novo Nordisk of milestone and royalty payments of $10 million.

-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

November 26, 2015 10:44 ET (15:44 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novo Nordisk Charts.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novo Nordisk Charts.